iSpecimen Stockholders Approve Reverse Stock Split of 1-for-10 to 1-for-100
The board will pick the exact ratio within that range, and the filing does not give an effective date.
iSpecimen Inc. · Nasdaq · Services-Commercial Physical & Biological Research
The board will pick the exact ratio within that range, and the filing does not give an effective date.
No open-market insider buying or selling in the Form 4s filed since July 24, 2026.
Submission of matters to a vote of security holders
AI summary, unreviewediSpecimen Inc. stockholders approve reverse stock split authorization at 1:10 to 1:100 ratio after adjourned special meeting
Submission of matters to a vote of security holders
Delisting notice / failure to meet listing standard
Entry into a material definitive agreement · Financial statements and exhibits
Departure/appointment of directors or officers · Financial statements and exhibits
Entry into a material definitive agreement · Financial statements and exhibits
Entry into a material definitive agreement · Termination of a material definitive agreement · Financial statements and exhibits